{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:33:01Z","timestamp":1783488781961,"version":"3.55.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2018.0235","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T14:03:56Z","timestamp":1529676236000},"page":"e180235","source":"Crossref","is-referenced-by-count":51,"title":["Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers"],"prefix":"10.1001","volume":"1","author":[{"given":"Dora H.","family":"Lin","sequence":"first","affiliation":[{"name":"Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Jones","sequence":"additional","affiliation":[{"name":"Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson M.","family":"Compton","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Heyward","sequence":"additional","affiliation":[{"name":"Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan L.","family":"Losby","sequence":"additional","affiliation":[{"name":"Division of Unintentional Injury Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene B.","family":"Murimi","sequence":"additional","affiliation":[{"name":"Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant T.","family":"Baldwin","sequence":"additional","affiliation":[{"name":"Division of Unintentional Injury Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeromie M.","family":"Ballreich","sequence":"additional","affiliation":[{"name":"Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Thomas","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bicket","sequence":"additional","affiliation":[{"name":"Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Porter","sequence":"additional","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonothan C.","family":"Tierce","sequence":"additional","affiliation":[{"name":"Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Caleb","family":"Alexander","sequence":"additional","affiliation":[{"name":"Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"issue":"43","key":"zoi180034r1","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers\u2014United States, 1999-2008.","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"zoi180034r3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jpain.2015.05.002","article-title":"Estimates of pain prevalence and severity in adults: United States, 2012.","volume":"16","author":"Nahin","year":"2015","journal-title":"J Pain"},{"key":"zoi180034r4","article-title":"STAT forecast: opioids could kill nearly 500,000 in U.S. in next decade.","author":"Blau","journal-title":"Stat"},{"issue":"1","key":"zoi180034r6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016.","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"zoi180034r7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.7326\/M16-2367","article-title":"Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians.","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi180034r8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"},{"issue":"1","key":"zoi180034r10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jama.298.1.61","article-title":"Prescription drug cost sharing: associations with medication and medical utilization and spending and health.","volume":"298","author":"Goldman","year":"2007","journal-title":"JAMA"},{"issue":"23","key":"zoi180034r11","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1056\/NEJMsa030954","article-title":"The effect of incentive-based formularies on prescription-drug utilization and spending.","volume":"349","author":"Huskamp","year":"2003","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi180034r12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.7326\/M17-1823","article-title":"Medicare formulary coverage restrictions for prescription opioids, 2006 to 2015.","volume":"167","author":"Samuels","year":"2017","journal-title":"Ann Intern Med"},{"issue":"12","key":"zoi180034r13","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1377\/hlthaff.2016.0623","article-title":"Survey highlights differences in Medicaid coverage for substance use treatment and opioid use disorder medications.","volume":"35","author":"Grogan","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"zoi180034r14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jsat.2015.09.004","article-title":"The effect of a payer-mandated decrease in buprenorphine dose on aberrant drug tests and treatment retention among patients with opioid dependence.","volume":"61","author":"Accurso","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"zoi180034r15","first-page":"437","article-title":"Low back pain (chronic).","volume":"84","author":"Chou","year":"2010","journal-title":"BMJ Clin Evid"},{"issue":"6","key":"zoi180034r16","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/annrheumdis-2013-204428","article-title":"The global burden of low back pain: estimates from the Global Burden of Disease 2010 study.","volume":"73","author":"Hoy","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"zoi180034r17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1001\/archinternmed.2008.543","article-title":"The rising prevalence of chronic low back pain.","volume":"169","author":"Freburger","year":"2009","journal-title":"Arch Intern Med"},{"key":"zoi180034r20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF00988593","article-title":"Grounded theory research: procedures, canons, and evaluative criteria.","volume":"13","author":"Corbin","year":"1990","journal-title":"Qual Sociol"},{"issue":"1","key":"zoi180034r24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.clinthera.2011.01.012","article-title":"Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study.","volume":"33","author":"Lu","year":"2011","journal-title":"Clin Ther"},{"issue":"5","key":"zoi180034r25","first-page":"447","article-title":"Implementation of an opioid management initiative by a state Medicaid program.","volume":"20","author":"Garcia","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"issue":"5051","key":"zoi180034r26","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010-2015.","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"zoi180034r27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"10","key":"zoi180034r28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use\u2014United States, 2006-2015.","volume":"66","author":"Shah","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi180034r2","volume-title":"Provisional Drug Overdose Death Counts","author":"Ahmad","year":"2017"},{"key":"zoi180034r9","volume-title":"National Pain Strategy: A Comprehensive Population Health-Level Strategy for Pain","author":"Interagency Pain Research Coordinating Committee","year":"2016"},{"key":"zoi180034r29","volume-title":"The Opioid Epidemic: From Evidence to Impact","author":"Alexander","year":"2017"},{"key":"zoi180034r5","unstructured":"KatzJ. Drug deaths in America are rising faster than ever.New York Times. https:\/\/www.nytimes.com\/interactive\/2017\/06\/05\/upshot\/opioid-epidemic-drug-overdose-deaths-are-rising-faster-than-ever.html?mcubz=0. Published June 5, 2017. Accessed September 22, 2017."},{"key":"zoi180034r18","unstructured":"Kaiser Family Foundation. Health insurance coverage of the total population.http:\/\/www.kff.org\/other\/state-indicator\/total-population\/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D. Published 2017. Accessed March 8, 2018."},{"key":"zoi180034r19","unstructured":"Kaiser Family Foundation. Medicare Advantage.http:\/\/www.kff.org\/medicare\/fact-sheet\/medicare-advantage\/. Published October 10, 2017. Accessed March 8, 2018."},{"key":"zoi180034r21","unstructured":"New Jersey Academy of Family Physicians. New prescribing law for treatment of acute and chronic pain.https:\/\/www.njafp.org\/content\/new-prescribing-law-treatment-acute-and-chronic-pain. Published February 16, 2017. Accessed September 13, 2017."},{"key":"zoi180034r22","unstructured":"Massachusetts Medical Society. What you must know about the new opioid laws.http:\/\/www.massmed.org\/News-and-Publications\/Vital-Signs\/What-You-Must-Know-About\u2013the-New-Opioid-Laws\/#.WhIwtFWnGUk. Published April 1, 2016. Accessed September 13, 2017."},{"key":"zoi180034r23","unstructured":"JapsenB. CVS health increases restrictions on opioids.Forbes. https:\/\/www.forbes.com\/sites\/brucejapsen\/2017\/09\/21\/cvs-health-increases-restrictions-on-opioids\/#5ab16b24720b. Published September 21, 2017. Accessed September 22, 2017."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/1\/2\/e180235\/17326704\/lin_2018_oi_180034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T15:51:04Z","timestamp":1551196264000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2018.0235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.0235","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]}}}